In Vivo and In Vitro Capabilities
Extensive in vitro and in vivo capabilities and expertise
CXR has extensive in-house in vivo capabilities and in vitro capabilities, supported by a full suite of modern laboratory equipment (including two Sciex 6500 triple-quad mass spectrometers, two further triple-quad mass spectrometers, a Xevo G2-XS QTOF/TOF plus a further TOF mass spectrometer, GC, GC-MS, HPLC, advanced microscopy and image analysis, a liquid scintillation counter, Quantitative PCR, full capability in Agilent gene analysis and Ingenuity bioinformatics).
Microarrays & Toxicogenomics
mRNA, miRNA, cGH, ChIP on chip, methylation…
CXR Biosciences employs its microarrays and toxicogenomics services to provide a detailed understanding of the cellular responses to compounds.
This is useful in a variety of research applications, but especially in Investigative Toxicology where it is thoughtfully applied to generate hypotheses about the mechanism of toxicity.
Mechanistic Assays and Screens
Project specific, issue-dependent assays developed as required